Insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF) have been implicated in the intrinsic response of the heart to myocardial infarction (MI), and it has been postulated that exogenous administration of one or both of these growth factors may enhance myocardial repair and regeneration. We hypothesized that a biodegradable, elastomeric poly(ester urethane)urea (PEUU) capable of sustained, local delivery of IGF-1 or HGF to ischemic myocardium would improve left ventricular (LV) dimension and function. PEUU scaffolds without growth factor or scaffolds containing either IGF-1 or HGF were applied onto the hearts of rats injured by MI. Improvement in LV function and restoration of LV wall thickness, muscle mass, and angiogenes...
Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of hea...
[EN] Contractile restoration of myocardial scars remains a challenge with important clinical implica...
Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic opportunity f...
Insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF) have been implicated in the ...
The continued risk of death due to heart failure has spurred the advancement of biomaterials-based t...
Acute myocardial infarction (MI) caused by ischemia and reperfusion (IR) is the most common cause of...
The challenge of tissue engineering of the infarcted heart is how to improve stem cell engraftment, ...
It is increasingly appreciated that the properties of a biomaterial used in intramyocardial injectio...
The use of injectable scaffolds to repair the infarcted heart is receiving great interest. Thermosen...
Scaffolds for myocardial Tissue Engineering (TE) should display biomimetic properties respect to car...
Myocardial infarction (MI) can be tackled by implanting cardiac patches which provide mechanical sup...
<div><p>Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic oppor...
Treatment of cardiac diseases involves transplantation of donor hearts, since the damaged heart has ...
Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of hea...
[EN] Contractile restoration of myocardial scars remains a challenge with important clinical implica...
Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic opportunity f...
Insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF) have been implicated in the ...
The continued risk of death due to heart failure has spurred the advancement of biomaterials-based t...
Acute myocardial infarction (MI) caused by ischemia and reperfusion (IR) is the most common cause of...
The challenge of tissue engineering of the infarcted heart is how to improve stem cell engraftment, ...
It is increasingly appreciated that the properties of a biomaterial used in intramyocardial injectio...
The use of injectable scaffolds to repair the infarcted heart is receiving great interest. Thermosen...
Scaffolds for myocardial Tissue Engineering (TE) should display biomimetic properties respect to car...
Myocardial infarction (MI) can be tackled by implanting cardiac patches which provide mechanical sup...
<div><p>Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic oppor...
Treatment of cardiac diseases involves transplantation of donor hearts, since the damaged heart has ...
Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of hea...
[EN] Contractile restoration of myocardial scars remains a challenge with important clinical implica...
Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic opportunity f...